Invention Grant
- Patent Title: Targeted delivery of botulinum toxin to the sphenopalatine ganglion
- Patent Title (中): 目标将肉毒毒素递送至蝶腭神经节
-
Application No.: US13158894Application Date: 2011-06-13
-
Publication No.: US08530425B2Publication Date: 2013-09-10
- Inventor: Andrew M. Blumenfeld
- Applicant: Andrew M. Blumenfeld
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Brigitte Phan; Ted Chan; Debra Condino
- Main IPC: A61K38/16
- IPC: A61K38/16 ; A61P25/06
Abstract:
Botulinum toxin, among other presynaptic neurotoxins is used for the treatment and prevention of migraine and other headaches associated with vascular disorders. Presynaptic neurotoxins are delivered focally, targeting the sphenopalatine ganglion. Exemplary delivery is carried out by way of injection.
Public/Granted literature
- US20120053127A1 TARGETED DELIVERY OF BOTULINUM TOXIN TO THE SPHENOPALATINE GANGLION Public/Granted day:2012-03-01
Information query
IPC分类:
